Time-restricted Eating Among Pregnant Females With Severe Obesity
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Time Restricted Eating.
- Кому может быть актуально
- Состояния в реестре: Obesity, Morbid, Time Restricted Eating, Pregnancy Weight Gain. Базовые параметры: 18 лет — 44 лет · Женщины.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- США
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
A Pilot Study of Time-restricted Eating Among Pregnant Females With Severe Obesity
Обзор
In the United States, a body mass index (BMI) of at least 35.0 kg/m2 affects about 15% of women of reproductive age. Severe obesity is a significant predictor of adverse perinatal outcomes including gestational diabetes mellitus, pre-eclampsia, premature birth, and at its most severe, fetal death, birth defects and a three-fold greater risk of maternal mortality. Observational studies suggest weight maintenance and even modest body fat loss and altering the maternal metabolic milieu (availability of glucose and lipids) in the gestational period may be important to reducing perinatal health risks among pregnant females with severe obesity. The proposed research aims to assess time-restricted eating in the 2nd and 3rd trimesters of pregnancy to explore the effects on maternal weight, and perinatal health outcomes compared to standard clinical care.
Подробное описание
Severe obesity is a contributor to adverse perinatal outcomes. The prevalence of severe obesity is on the rise in the United States (U.S.), having increased from 6.4% of the adult population in 2011-2012 to just over 9% of adults in 2017-2018. The prevalence of severe obesity among reproductive age females is approximately 10%. This is an alarming statistic given severe obesity is a predictor of adverse perinatal outcomes including gestational diabetes mellitus, preeclampsia, premature birth (both spontaneous and medically indicated), and at its most severe, fetal death, birth defects, and a three-fold greater risk of maternal mortality. Observational studies suggest weight maintenance and even modest body fat loss and altering the maternal metabolic milieu (availability of glucose and lipids) in the gestational period may be important to reducing perinatal health risks among pregnant females with severe obesity. Existing lifestyle interventions (calorie control/dietary pattern changes/physical activity) have showed modest effects on attenuating excess gestational weight gain and modest effects on perinatal health outcomes among pregnant females with obesity. Time- restricted eating, where an individual simply watches the clock and consumes calories within a particular eating window, is a simple and highly accessible eating pattern that has the potential to minimize gestational weight gain, reduce excess glucose and lipids, and improve metabolic health among pregnant females with severe obesity all of which could translate to improved perinatal health outcomes. Yet there are no clinical trials of time-restricted eating in pregnancy. The investigators aim to test the safety, feasibility, and acceptability of time-restricted eating among 60 pregnant females with severe obesity. The investigators will examine time-restricted eating safety, feasibility and acceptability (8-hr eating window in the 2nd trimester \& 10-hr eating window in the 3rd trimester), and explore its effects on weight, cardiometabolic risk markers and perinatal health outcomes vs. Standard Care. The intervention will begin between 14 - \< = 20 weeks gestational age and continue through admission for labor and delivery. The study will involve weekly meetings with a nutritionist, and research visits at baseline (\~17 weeks gestational age), 27-29 weeks gestational age and 35-37 weeks gestational age as well as monthly check-ins for maternal and fetal health monitoring. Maternal and neonatal data from labor and delivery will also be collected from electronic health records. Glucose will be continuously monitored for 10 days at 20 weeks gestational age and 34 weeks gestational age (optional). The goal of our work is to reduce and prevent adverse perinatal outcomes among pregnant females with severe obesity. Given the relative simplicity of time-restricted eating it can be easily disseminated in clinic demonstrating its strong potential for wide-scale public health impact.
Вмешательства
- Поведенческое Time Restricted Eating
The time-restricted eating arm will be instructed to eat ad libitum during an 8-hr window daily (10am - 6pm OR 11am - 7pm) in the 2nd trimester and 10-hr eating window from (9am - 7pm OR 10am - 8pm) in the 3rd trimester and abstain from caloric foods and beverages for the remaining 14-16 hours.
Первичные конечные точки
- Recruitment Feasibility [Срок оценки: From 6 months through 32 months (the funding period is 36 months)]
- Trial safety - Maternal Complete Blood Count [Срок оценки: Baseline (14-20 weeks gestational age) and monthly through labor and delivery, about 6 months]
- Trial safety - Non-stress Test for Fetal Safety [Срок оценки: 29-31 weeks gestational age and 35-37 weeks gestational age]
- Intervention acceptability [Срок оценки: 25-27 weeks gestational age and 35-37 weeks gestational age]
- Research visit feasibility [Срок оценки: Baseline, 25-27 weeks gestational age and 35-37 weeks gestational age]
- Intervention (TRE) session feasibility [Срок оценки: Weekly from baseline through labor and delivery, about 6 months]
- TRE adherence [Срок оценки: Daily from enrollment to labor and delivery (TRE arm only), about 6 months]
- Trial safety - Maternal health checks [Срок оценки: Weekly from baseline to labor and delivery, about 6 months, % and n for health events reported by study arm]
- Trial safety - Maternal outcomes [Срок оценки: Labor and delivery]
- Trial safety - Neonatal outcomes [Срок оценки: Labor and delivery]
Вторичные конечные точки (8)
- Maternal Body Weight [Срок оценки: Baseline (14-20 weeks), 25-27 weeks gestational age, 35-37 weeks gestational age]
- Maternal Fasting Blood Glucose [Срок оценки: Baseline (14-20 weeks gestational age), 25-27 weeks gestational age, 35-37 weeks gestational age]
- Maternal Fasting Insulin [Срок оценки: Baseline (14-20 weeks gestational age), 25-27 weeks gestational age, 35-37 weeks gestational age]
- Maternal Fasting Blood Lipids [Срок оценки: Baseline (14-20 weeks gestational age), 25-27 weeks gestational age, 35-37 weeks gestational age]
- Maternal C-reactive protein [Срок оценки: Baseline (14-20 weeks gestational age), 25-27 weeks gestational age, 35-37 weeks gestational age]
- Maternal Systolic Blood Pressure [Срок оценки: Baseline (14-20 weeks gestational age), 25-27 weeks gestational age, 35-37 weeks gestational age]
- Maternal Diastolic Blood Pressure [Срок оценки: Baseline (14-20 weeks), 25-27 weeks gestational age, 35-37 weeks gestational age]
- Maternal Hb A1c [Срок оценки: Baseline (14-20 weeks gestational age), 25-27 weeks gestational age, 35-37 weeks gestational age]
Критерии участия
Критерии включения
- Female based on sex assigned at birth
- Preconception body mass index (BMI) 35.0 - 60 kg/m2
- Singleton pregnancy
- Age 18-44 years old
- 14 - < = 20 weeks gestational age
- Fluency in English to provide consent and complete study procedures
- Ability to provide informed consent
- Cleared by study doctor and the obstetrician/mid-wife provider to participate
- Access to a smartphone to complete intervention procedures
Критерии исключения
- Deemed medically high risk
- Multiple pregnancy (e.g., twins)
- Type 1 or 2 diabetes mellitus
- Early gestational diabetes (diagnosed at < = to17 weeks gestational age through an oral glucose tolerance test)
- Currently eating ≤ 12 hours daily
- Autoimmune disorder (e.g., rheumatoid arthritis)
- iron deficiency anemia
- Inflammatory bowel disease
- Previous spontaneous preterm birth
- History of bariatric surgery
- Night shift work
- Currently incarcerated
- Eating disorder
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Да
Дизайн исследования
- Распределение
- Рандомизированное
- Модель
- Параллельные группы
- Маскирование
- Простое слепое
- Основная цель
- Профилактика
Центры проведения
США · 1 центр
- University of Illinois at Chicago College of Applied Health Sciences — Chicago
Идентификаторы
NCT: NCT06477120 · 2024-0138 · 5R01DK136085-02